Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17848901 | 1.00 | NR1H4 (0.57) | NR1H4HSD17B13 | |
| SCHEMBL17839616 | 1.00 | NR1H4 (0.57) | NR1H4HSD17B13 | |
| SCHEMBL17856096 | 1.00 | NR1H4 (0.57) | NR1H4HSD17B13 | |
| SCHEMBL17848899 | 1.00 | NR1H4 (0.57) | NR1H4HSD17B13 | |
| SCHEMBL19189978 | 0.89 | NR1H4 (0.56) | NR1H4HSD17B13 | |
| SCHEMBL17839702 | 0.89 | NR1H4 (0.54) | NR1H4HSD17B13 | |
| SCHEMBL19189592 | 0.87 | NR1H4 (0.55) | NR1H4HSD17B13 | |
| SCHEMBL9957522 | 0.87 | NR1H4 (0.55) | NR1H4HSD17B13 | |
| SCHEMBL29555981 | 0.87 | NR1H4 (0.55) | NR1H4HSD17B13 | |
| SCHEMBL22654683 | 0.86 | NR1H4 (0.64) | NR1H4HSD17B13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233850-B1 | HYDROXY CONTAINING FXR (NR1H4) MODULATING COMPOUNDS | GILEAD SCIENCES INC (US) | 2019-04-03 | — | — | EP | disclosed |
| US-9751874-B2 | Hydroxy containing FXR (NR1H4) modulating compounds | GILEAD SCIENCES, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-20160176861-A1 | HYDROXY CONTAINING FXR (NR1H4) MODULATING COMPOUNDS | GILEAD SCIENCES, INC. | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160176861-A1 | HYDROXY CONTAINING FXR (NR1H4) MODULATING COMPOUNDS | NR1H4, NR1H3, NR1H2 | NR1H4 1/4885HSD17B13 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.